MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver Injury
The last decade has witnessed significant advancements in our understanding of how small noncoding RNAs, such as microRNAs (miRNAs), regulate disease progression. One such miRNA, miR-221, has been shown to play a key role in the progression of liver fibrosis, a common feature of most liver diseases....
Main Authors: | Jovana Markovic, Amar Deep Sharma, Asha Balakrishnan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/8/1767 |
Similar Items
-
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review
by: Maria Teresa Di Martino, et al.
Published: (2022-03-01) -
Inhibition of hepatocellular carcinoma growth via modulation of the miR-221/SOX11 axis by curcumin and berberine
by: Sheng Li, et al.
Published: (2023-12-01) -
Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer
by: Chun-Wen Cheng, et al.
Published: (2018-08-01) -
From NAFLD to HCC: Advances in noninvasive diagnosis
by: Qinchen Xu, et al.
Published: (2023-09-01) -
Prognostic Value of microRNA-221/2 and 17-92 Families in Primary Glioblastoma Patients Treated with Postoperative Radiotherapy
by: Elena Schnabel, et al.
Published: (2021-03-01)